15th Vitreoretinal Symposium 2015
Scientific programm: Symposium
Friday, 25th September 2015 — 16.00 - 17.40
7th scientific session:
Breakthrough in medical and surgical retina
Chairmen and moderation:
Albert J. Augustin (Karlsruhe/D)
Lars-Olof Hattenbach (Ludwigshafen/D) |
| 33 |
Norbert Jahn (Pharm-Allergan GmbH, Frankfurt am Main/D)
Intravitreales Dexamethason-Implantat bei der BehandlungDiabetischer Makulaödeme |
| 34 |
Paul B. Griggs (Seattle/USA)
Protocoll-TResults |
| 35 |
Albert J. Augustin (Karlsruhe/D)
Intravitreal Dexamethason-Implants for the treatment of DME |
| 36 |
36 Tamer Mahmoud (Durham/USA)
Surgical challenges of submacular hemorrhage.Outcomes and complications |
| 37 |
Lars-Olof Hattenbach (Ludwigshafen/D)
Praktische Erfahrungen mit der Anwendung eines Mikroimplantats |
| 38 |
Martin Heßling (Ulm/D)
Disinfection with UV LEDs and spectral analysis |
| 39 |
Karl T. Boden (Sulzbach/D)
Datenübersicht zu Wirksamkeit und Sicherheit des Fluocinolon Implantats |
| 40 |
Hugo Quiroz-Mercado (Denver/USA)
Update on retinopathy of prematurity treatment |
| 41 |
Sundaram Natarajan (Mumbai/IND)
IPCV - A diagnostic & Management Challenge |
| 42 |
Norbert F. Schrage (Köln/D)
Postoperativ Maculaedema: Curse of Intervention |
| 43 |
Sabine Finkmann(Alimera Sciences Ophthalmologie GmbH, Berlin/D)
Verschreibung und Abrechenbarkeit von Fluocinolon Implantaten |
| |
|
| 17.40 - 17:55 |
Panel 4
Moderators:
Albert J. Augustin (Karlsruhe/D)
Lars-Olof Hattenbach (Ludwigshafen/D)
|
Copyright © VRS-online, 1999-.
All rights reserved. Impressum, rechtliche Hinweise
HTML & Webdesign: SPALLEK.COM